[go: up one dir, main page]

PE20030207A1 - Soluciones de acido acetilsalicilico - Google Patents

Soluciones de acido acetilsalicilico

Info

Publication number
PE20030207A1
PE20030207A1 PE2001000218A PE2001000218A PE20030207A1 PE 20030207 A1 PE20030207 A1 PE 20030207A1 PE 2001000218 A PE2001000218 A PE 2001000218A PE 2001000218 A PE2001000218 A PE 2001000218A PE 20030207 A1 PE20030207 A1 PE 20030207A1
Authority
PE
Peru
Prior art keywords
volume
acid solutions
solvent
solution
water
Prior art date
Application number
PE2001000218A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Martina Wirtz
Dietmar Bahn
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE20030207A1 publication Critical patent/PE20030207A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • A61K31/612Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A SOLUCIONES DE 3g A 30 g DE ACIDO ACETILSALICILO, CONTENIENDO EL DISOLVENTE DE 1 A 20% EN VOLUMEN DE AGUA Y 80 A 99% EN VOLUMEN DE DISOLVENTE ORGANICO EN 100 ml DE SOLUCION. EL DISOLVENTE ORGANICO SE SELECCIONA DE ETANOL, PROPANO, ISOPROPANOL, BUTANO, ISOBUTANOL, ENTRE OTROS. EL DISOLVENTE COENTINE DE 30% A 80% DE VOLUMEN DE ETER , DE 17% A 67% DE VOLUMEN DE ALCOHOL O ACETONA Y DE 3% A 10% EN VOLUMEN DE AGUA. LA SOLUCION ES UTIL PARA EL TRATAMIENTO TOPICO DEL DOLOR COMO HERPES ZOSTER, PRURITO, NEURODERMITIS
PE2001000218A 2000-03-07 2001-03-06 Soluciones de acido acetilsalicilico PE20030207A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10011032A DE10011032A1 (de) 2000-03-07 2000-03-07 Acetylsalicylsäure-Lösungen

Publications (1)

Publication Number Publication Date
PE20030207A1 true PE20030207A1 (es) 2003-04-16

Family

ID=7633806

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000218A PE20030207A1 (es) 2000-03-07 2001-03-06 Soluciones de acido acetilsalicilico

Country Status (9)

Country Link
EP (1) EP1263441A2 (es)
AR (1) AR028237A1 (es)
AU (1) AU2001272099A1 (es)
DE (1) DE10011032A1 (es)
GT (1) GT200100035A (es)
HN (1) HN2001000039A (es)
PE (1) PE20030207A1 (es)
SV (1) SV2002000339A (es)
WO (1) WO2001066115A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070196460A1 (en) * 2004-02-16 2007-08-23 Yukiko Inamoto External preparation for treating skin or mucosal injury caused by viral infection
WO2007125492A2 (en) * 2006-05-02 2007-11-08 Pfeinsmith S.A. (Pty) Ltd Acidic composition
JP7335232B2 (ja) * 2017-05-30 2023-08-29 ローシャン ファーマシューティカルズ,インコーポレーテッド 安定な滅菌性且つ結晶性o-アセチルサリチル酸(アスピリン)のバイアル内堆積物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
WO1995019759A1 (en) * 1994-01-24 1995-07-27 The Procter & Gamble Company Process for solubilizing difficultly soluble pharmaceutical actives
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
EP1263441A2 (de) 2002-12-11
AR028237A1 (es) 2003-04-30
AU2001272099A1 (en) 2001-09-17
GT200100035A (es) 2001-12-18
HN2001000039A (es) 2001-07-09
WO2001066115A3 (de) 2002-02-14
WO2001066115A2 (de) 2001-09-13
SV2002000339A (es) 2002-06-07
DE10011032A1 (de) 2001-09-13

Similar Documents

Publication Publication Date Title
PE49296A1 (es) Procedimiento para preparar clorhidrato de 1-(2`-desoxi-2',2'-difluoro-d-ribofuranosil)-4-aminopirimidin-2-ona
MD1587B2 (en) Retinoid composition and utilization thereof as therapeutic remedy for topical cutaneous application
ES2052518T3 (es) Agente viricida con efecto de amplio espectro.
PE20050945A1 (es) Ester de rapamicin-42 amorfo con el acido 3-hidroxi-2-(hidroximetil)-2-metilpropionico y sus composiciones farmaceuticas
BRPI0307117B8 (pt) amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
DE3579337D1 (de) Dermatologische fungizide loesung.
AU1018992A (en) Cosmetic composition
ES2125535T5 (es) Mezclas, que contienen isocianatos emulsionables en agua.
PE20030207A1 (es) Soluciones de acido acetilsalicilico
FR2461499A1 (fr) Composition pharmaceutique a base d'extraits de myrtille
IT1265001B1 (it) Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico
ES2143443T3 (es) Espesantes polimeros para composiciones acuosas.
ES2197632T3 (es) Procedimiento de preparacion de aloina por extraccion.
ATE376427T1 (de) Pharmazeutische zusammensetzungen aus bartflechten (usnea barbata) und johanniskraut (hypericum perforatum) sowie ihre verwendung
Dubasi et al. Applications of Alum (KAl (SO4) 2.12 H2O) in organic synthesis and as catalysis: a quinquennial update (2017-2022)
AR010178A1 (es) Preparados farmaceuticos que contienen como principio activo cilansetron, empleo de aditivos y procedimiento para la produccion de dichos preparados
CA2067807A1 (en) Alcoholic aqueous gel-type phospholipid composition, its use and topical preparations containing it
ES2078054T3 (es) Curtientes diluibles de triformiato de aluminio en forma altamente concentrada soluble en agua y estable al almacenamiento y su empleo.
BR9807056A (pt) Uso de álcool diclorobenzìlico, e preparação para tratamento tópico da inflamação
ES8705463A1 (es) Un procedimiento para la preparacion de 1-metil-4,5-dihi- droorotil-histidil-prolinamida
CY1107814T1 (el) Θεραπεια παθησεων υπερπολλαπλασιασμου των επιφανειων του σωματος
JPS5655307A (en) Opacifying cosmetic
GT196808903A (es) Compuestos organicos y proceso.
Ali et al. Screening for the antimicrobial properties of the leaves of Calophyllum inophyllum Linn.(Guttiferae)
GB1455613A (en) Antibiotic a-287 and process for production thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal